Recruiting
Neuroblastoma
RecruitingStudy on High-Risk Neuroblastoma Treatment with Busulfan, Melphalan, and Drug Combination for Patients with Insufficient Metastatic Response
Registered drugNo placebo
Study on High-Risk Neuroblastoma Treatment with Busulfan, Melphalan, and Drug Combination for Patients with Insufficient Metastatic Response
Registered drugNo placebo
- Disease:Neuroblastoma
- Substances:BusulfanCarboplatin+9
Countries:
France
France- Participants:0–17 years · 18–64 years
- Substances:Busulfan
- Sponsor:Institut Gustave Roussy



